Symbol="IKNA"
AssetType="Common Stock"
Name="Ikena Oncology Inc"
Description="Ikena Oncology, Inc., a targeted oncology company, is focused on developing new cancer therapies that target key signaling pathways that drive cancer formation and spread. The company is headquartered in Boston, Massachusetts."
CIK="1835579"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="50 NORTHERN AVE., BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="227057000"
EBITDA="-68655000"
PERatio="None"
PEGRatio="None"
BookValue="3.724"
DividendPerShare="0"
DividendYield="0"
EPS="-1.8"
RevenuePerShareTTM="0.484"
ProfitMargin="0"
OperatingMarginTTM="-3.958"
ReturnOnAssetsTTM="-0.228"
ReturnOnEquityTTM="-0.403"
RevenueTTM="17547000"
GrossProfitTTM="-48703000"
DilutedEPSTTM="-1.8"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.57"
AnalystTargetPrice="17.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.126"
PriceToBookRatio="0.66"
EVToRevenue="0.208"
EVToEBITDA="0.968"
Beta="0.835"
num_52WeekHigh="7.64"
num_52WeekLow="1.94"
num_50DayMovingAverage="6.36"
num_200DayMovingAverage="4.357"
SharesOutstanding="36270000"
DividendDate="None"
ExDividendDate="None"
symbol="IKNA"
open="5.54"
high="5.95"
low="5.16"
price="5.37"
volume="102751.00"
latest_trading_day="2023-07-28"
previous_close="5.54"
change="-0.17"
change_percent="-3.0686%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="1"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="99"
Volume_recent_avg="95273"
Change_recent_avg="0.02"
Delta_recent_avg="0.51"
Variance_recent_avg="0.25"
Change_ratio_recent_avg="0.41"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="99"
Aroon_momentum_negative="1"
image_negative_thumbnail_id_1="500"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_negative_thumbnail_id_2="175"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0001.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="613"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0095.jpeg"
image_positive_thumbnail_id_2="978"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0140.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
